Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05705_nanopub.RAxshuAJnW-4oD-bXBQKCNh3r89J59zDkmx7XyQD5_q1g#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05705 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05705 label "ALS-08 [drugbank:DB05705]" assertion.
- drugbank:DB05705 seeAlso DB05705 assertion.
- drugbank:DB05705 description "ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc." assertion.
- drugbank:DB05705 identifier "drugbank:DB05705" assertion.
- drugbank:DB05705 title "ALS-08" assertion.
- drugbank:DB05705 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05705 drugbank_vocabulary:drugbank-id "DB05705" assertion.
- drugbank:DB05705 bio2rdf_vocabulary:x-identifiers.org DB05705 assertion.
- drugbank:DB05705 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05705" assertion.
- drugbank:DB05705 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05705 bio2rdf_vocabulary:identifier "DB05705" assertion.